Company
Headquarters: Roodepoort, South Africa
Employees: 5,957
CEO: Mr. Ahmed Banderker C.A., CA (SA)
R2.49 Billion
ZAR as of July 1, 2024
US$135.8 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
AfroCentric Investment Corporation Limited, an investment holding company, provides health administration and health risk management solutions to the healthcare sector. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers documentation based care equipment and administration services to 12 musculoskeletal treatment centers; and engages in the retail and wholesale of pharmaceutical products under the Pharmacy Direct, MMed, Scriptpharm Risk Management, Curasana Wholesaler, and Activo Health names. The company also provides HIV and other healthcare management solutions. It operates in South Africa, Botswana, Mauritius, Namibia, Eswatini, and Zimbabwe. AfroCentric Investment Corporation Limited was incorporated in 2008 and is based in Roodepoort, South Africa.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
AfroCentric Investment Corp Ltd has the following listings and related stock indices.
Stock: JSE: ACT wb_incandescent